Premium
Crisis management: The medical director's response
Author(s) -
Fitzgerald J. D.
Publication year - 1992
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.2630010312
Subject(s) - medicine , crisis management , drug reaction , frame (networking) , key (lock) , process management , public relations , risk analysis (engineering) , drug , business , management , computer security , pharmacology , computer science , political science , telecommunications , economics
This paper discusses the incidence and type of adverse drug reactions in relationship to their impact on a pharmaceutical company. It emphasizes that managing such a crisis requires skills in organizational processes that are not normally needed in the daily operation of a commercial enterprise. The role of the medical director is defined as it relates to the management of such a crisis. The key processes of managing complex interdisciplinary groups, and the problem of re‐evaluating the risk/benefit profile of the drug in question, within a constrained time frame and with an inadequate database are described. The principles of crisis communication skills are outlined. A case is made for giving a higher priority to crisis prevention by adopting certain straightforward precautions.